Intensity not paramount for physical training during cancer therapy

February 03, 2021

People receiving treatment for cancer are known to feel better with physical training. But does it make any difference how vigorously they exercise? A new study by researchers at Uppsala University shows that whether the training is intensive or rather less strenuous, its effect is roughly the same. The results are published in the journal Scandinavian Journal of Medicine and Science in Sports.

Physical activity and training during cancer therapy improve physical and mental health, and may also reduce the most common side effects of the treatment. This has been confirmed in several international studies. Many patients suffer from cancer-related fatigue, and both resistance and endurance training are known to lessen fatigue.

On the other hand, whether the intensity of the training is of any significance has yet to be clarified. Nor has it been ascertained whether extra support in the form of goal-setting, planning and self-monitoring of exercise brings improved results. To answer these questions, a randomised, controlled study known as Phys-Can (Physical training and Cancer) was implemented at the Universities of Uppsala, Linköping and Lund.

A total of 577 participants aged 30-84, recently diagnosed with breast, prostate or colorectal cancer, were randomised to undergo resistance and endurance training at either high or low-to-moderate intensity. In addition, half were randomly assigned to receive extra support in their training.

The resistance training was provided in instructor-led groups at Sweden's largest keep-fit club while the endurance training was home-based. The extra support given to half the participants was primarily a matter of assistance in planning their home-based endurance training and recording it in their diaries. The training period lasted six months.

After completion of the training, the two groups displayed differences. The group that had undergone high-intensity training suffered from somewhat less physical fatigue. They also had superior leg-muscle strength and slightly better fitness than the low-to-moderate intensity group. Regarding the extra support provided in the course of the training, no difference was found between the groups at follow-up. Accordingly, the additional support seems to have had no effect, given that the arrangements already entailed a great deal of support: thorough training instructions, a heart-rate monitor and instructor-led group training with other participants in a similar situation, for example.

"The conclusions we draw from the study are, first, that whether the training is of high or low-to-medium intensity doesn't seem to matter much. The groups' results didn't differ in a clinically relevant way - that is, there was no difference likely to make a difference in the patients' everyday life," says Ingrid Demmelmaier, Associate Professor of Physiotherapy at Uppsala University.

The researchers will return later with more results from the study concerning such aspects as the effects of the training on the participants' health in the longer term.
-end-
The Phys-Can project is led by Professor Karin Nordin of the Department of Public Health and Caring Sciences at Uppsala University.

Uppsala University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.